Substituted picolinamides as MAO-B inhibitors useful for treating obesity
US8138209B2 · kind B2 · utility
4Cited by
8References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2006 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Oct 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6512
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel compounds of formula I:that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.